🔗 Share this article

This year's prestigious award in Physiology or Medicine has been awarded for transformative findings that illuminate how the immune system attacks harmful infections while sparing the healthy tissues.

A trio of renowned scientists—Japan's Shimon Sakaguchi and US experts Mary Brunkow and Dr. Ramsdell—received this honor.

The research uncovered specialized "sentinels" within the immune system that remove rogue immune cells capable of harming the body.

These findings are now enabling innovative treatments for immune disorders and cancer.

These laureates will share a prize fund worth 11 million Swedish kronor.

Decisive Discoveries

"Their research has been decisive for understanding how the body's defenses functions and the reason we do not all develop serious autoimmune diseases," stated the head of the Nobel Committee.

This team's studies explain a fundamental question: In what way does the immune system defend us from countless invaders while keeping our healthy cells unharmed?

The body's protection system employs white blood cells that search for signs of disease, including viruses and bacteria it has never encountered.

These cells employ sensors—known as recognition units—that are produced randomly in a vast number of variations.

That gives the defense network the ability to combat a wide array of threats, but the randomness of the mechanism unavoidably produces immune cells that may target the host.

Protectors of the Immune System

Researchers earlier understood that some of these harmful defense cells were eliminated in the thymus—where white blood cells develop.

This year's award honors the identification of T-reg cells—known as the body's "security guards"—which travel through the body to neutralize any immune cells that attack the body's own tissues.

It is known that this process malfunctions in autoimmune diseases such as type-1 diabetes, multiple sclerosis, and RA.

The Nobel panel stated, "These findings have laid the foundation for a new field of investigation and spurred the development of innovative therapies, for example for cancer and immune disorders."

Regarding cancer, T-regs prevent the body from attacking the growth, so research are focused on lowering their quantity.

For self-attack disorders, trials are testing boosting regulatory T-cells so the body is not being harmed. A comparable method could also be useful in minimizing the chances of transplanted organ failure.

Pioneering Experiments

Prof Sakaguchi, from Osaka University, conducted experiments on mice that had their thymus removed, leading to self-attack conditions.

The researcher demonstrated that injecting defense cells from healthy mice could prevent the disease—implying there was a system for preventing defenders from attacking the body.

Mary Brunkow, from the a research center in Seattle, and Fred Ramsdell, currently at a biotech firm in a California city, were investigating an inherited autoimmune disease in rodents and humans that led to the discovery of a genetic factor vital for the way regulatory T-cells operate.

"The pioneering work has uncovered how the body's defenses is kept in check by regulatory T cells, preventing it from mistakenly targeting the healthy cells," commented a prominent physiology specialist.

"This work is a remarkable example of how fundamental biological research can have far-reaching implications for human health."